Xolair is the First Biologic Medicine Approved for CIU, a Burdensome Skin Condition that Can Cause Hives and Severe Itch and May Last Many Years. Nearly 50 Percent of Patients Have Inadequate Response to H1-antihistamines, Previously the Only Approved Therapy for CIU3. Approximately 1.5 Million People in U.S. have CIU.Continue reading
Author Archive: AZBio
Opportunity Alert: VisionGate CLIA Lab Director
VisionGate is dedicated to saving lives through early cancer detection and prevention. The Cell-CT™ is a revolutionary automated 3D cell imaging platform that generates high-resolution 3D biosignatures from intact cells. They are currently recruiting for a CLIA Lab Director.Continue reading
UA Med Students in Phoenix Learn Next Destination at Match Day
Class of 37 from Downtown Phoenix Campus Will Be Fourth to GraduateContinue reading
TGen recognized as ‘2014 Economic Driver’ by Greater Phoenix Chamber of Commerce
GPCC Impact Awards recognize ability, tenacity and sense of communityContinue reading
Susavion Biosciences, Inc. Selected to Present at Cavendish Global Health Impact Forum
Cerebral Palsy and the Potential of Cord Blood Stem Cells
Clinical trials evaluating newborn stem cells as a treatment for pediatric patients with cerebral palsy may improve the availability of future therapeutic optionsContinue reading
Sir Richard Branson Takes The Stage at BIO 2014
Sir Richard Branson to Participate in Keynote Lunch Interview at the 2014 BIO International Convention in San Diego.
Keynote luncheon to take place Tuesday, June 24Continue reading
TGen study identifies gene fusion as likely cause of rare type of thyroid cancer
Genomic sequencing of 62-year-old patient leads to new treatment optionContinue reading
SynCardia Total Artificial Heart Could Become the Life-Saving Answer to Heart Transplant Graft Failure
SynCardia Systems, Inc. Continues to Make Progress for Approval of the SynCardia Heart for Permanent Use to Save Patients Who Are Unlikely to Receive Another Donor HeartContinue reading
TGen-led study spotlights dog DNA role in developing new therapies for human cancers
Study shows timeframe for canine sample analysis fits clinical window for human medical advancementsContinue reading